norovirus infections

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

Not yet recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula polymorpha)
  • placebo
  • (no location specified)
Jun 14, 2023

Norovirus Infections Trial in New Zealand, United States (Open label Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11

Recruiting
  • Norovirus Infections
  • Open label Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose
  • +3 more
  • La Mesa, California
  • +12 more
Jan 12, 2023

Norovirus Infections, Norwalk Gastroenteritis Trial in Hebi (middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine, high-dose

Recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine
  • +2 more
  • Hebi, Henan, China
    qixian Center for Disease Control and Prevention
Oct 26, 2022

Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)

Completed
  • Norovirus Infections
  • VXA-GI.1.NN
  • Placebo Tablet
  • Cypress, California
  • +2 more
Sep 19, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    WCCT Global, Inc.
Sep 19, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN, Placebo Tablets, Norovirus GI.1 Norwalk Virus Inoculum)

Recruiting
  • Norovirus Infections
  • VXA-G1.1-NN
  • +2 more
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Norwalk Gastroenteritis, Norovirus Infections Trial in Hebi (Norovirus Bivalent (GI.1 / GII.4) Vaccine(low), Norovirus Bivalent

Completed
  • Norwalk Gastroenteritis
  • Norovirus Infections
  • Norovirus Bivalent (GI.1 / GII.4) Vaccine(low)
  • +4 more
  • Hebi, Henan, China
    qixian Center for Disease Control and Prevention
Apr 20, 2021

Norovirus Infections Trial in Cincinnati (Donor Breastmilk)

Terminated
  • Norovirus Infections
  • Donor Breastmilk
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Aug 18, 2020

Norovirus Infections Trial in Cincinnati (Norovirus challenge pool (GII.4, CIN-1))

Completed
  • Norovirus Infections
  • Norovirus challenge pool (GII.4, CIN-1)
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
May 6, 2014